A Message From Our Program Leader
As a breast surgeon, I see the future of cancer care going beyond the operating room, using AI-driven tools to make treatment more responsive, personalized, and human. That’s why my research centers on technology supporting each patient’s journey.
About Our Program
Our research program is built on collaboration, innovation, and translating science into real-world patient care. We partner with leading companies to study biomarkers critical to cancer care and evaluate emerging technologies in breast surgery. For example, we tested Perimeter intraoperative imaging and created a registry to track outcomes and guide best practices.
We work closely with plastic surgery colleagues, where a high volume of Deep Inferior Epigastric Artery Perforator (DIEP) flap reconstructions allows us to study and publish outcomes that directly impact quality of life.
Beyond surgical innovation, the Institute contributes to product development for symptom monitoring and chemotherapy side effect tracking, ensuring patients have a voice while giving clinicians real-time tools to respond.
Our team also applies machine learning to reported data, generating insights to guide personalized treatment, improve efficiency, and advanced care. Together, these efforts reflect our mission: Bridging technology with compassionate, patient-centered care, while training the next generation of physicians and researchers.
Breast Research Cancer Facts and Figures
Phoenix is a hub for digital health innovation with a strong infrastructure for oncology.
AI-driven tools can reduce the high cost of avoidable hospitalizations from chemo complications.
Phoenix’s diverse population can generate critical data to reduce healthcare disparities.
Breast Cancer Clinical Trials
We offer registries for Perimeter, Phyllodes, and Prophylactic mastectomies
